AIF1L as a Ferroptosis‐Linked Biomarker in Microsatellite States–Driven Colorectal Cancer: Functional and Diagnostic Insights From Multiomics Analysis
Human Mutation · 2025
DOI: 10.1155/humu/6663166 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Mutation, 2025. Verfasst von Yuanyuan Qin und 6 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Ferroptosis, Biomarkers, Tumor, Microsatellite Instability. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State Administration of Traditional Chinese Medicine of the People's Republic of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Microsatellite instability (MSI) serves as a crucial biomarker for immune checkpoint blockade therapy in colorectal cancer (CRC). However, only around 40% of MSI CRC patients benefit from ICB. Investigating the mechanisms underlying MSI CRC, particularly its association with cell death and the immune microenvironment, can provide insights to improve immunotherapy efficacy.
Methods
Transcriptomic and clinical data of MSI CRC patients were collected from TCGA and GEO databases. Differential expression analysis, weighted gene coexpression network analysis, and Cox regression models were employed to identify five cell death–related prognostic genes (POU4F1, AIF1L, SLC18A1, INSL4, and HOXC6). Single‐cell analysis, immune infiltration analysis, and in vitro and in vivo experiments were conducted to validate their roles in MSI CRC.
Results
The five‐gene risk model effectively stratified high‐ and low‐risk groups and predicted survival differences (AUC > 0.6). AIF1L exhibited elevated expression in MSI‐H groups and demonstrated a significant correlation with ferroptosis and immune cell infiltration. In vitro experiments showed that AIF1L boosted cell proliferation and migration via modulating ferroptosis, showing correspondence with in vivo experiments. Moreover, enrichment analysis revealed that AIF1L participated in immune‐related signaling pathways, potentially impacting the tumor microenvironment and patient prognosis.
Conclusion
AIF1L may regulate MSI CRC progression by promoting ferroptosis, serving as a prospective biomarker for prognosis and a therapeutic target for personalized therapy. This study uncovers new mechanisms in MSI CRC and provides a foundation for optimizing immunotherapy, though further investigation into its specific roles is needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
- Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
- School of Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
ORCID-Profile: Li Li, Mianhua Wu
Förderung
- State Administration of Traditional Chinese Medicine of the People's Republic of China
- National Natural Science Foundation of China
Zitieren
APA
Qin, Y., Zhou, H., Zhu, L., Li, W., Jiang, Z., Li, L., & Wu, M. (2025). AIF1L as a Ferroptosis‐Linked Biomarker in Microsatellite States–Driven Colorectal Cancer: Functional and Diagnostic Insights From Multiomics Analysis. Human Mutation. https://doi.org/10.1155/humu/6663166
Vancouver
Qin Y, Zhou H, Zhu L, Li W, Jiang Z, Li L, et al. AIF1L as a Ferroptosis‐Linked Biomarker in Microsatellite States–Driven Colorectal Cancer: Functional and Diagnostic Insights From Multiomics Analysis. Human Mutation. 2025. doi:10.1155/humu/6663166
BibTeX
@article{Qin2025,
author = {Qin, Yuanyuan and Zhou, Hongli and Zhu, Lingyan and Li, Wenting and Jiang, Zequn and Li, Li and Wu, Mianhua},
title = {AIF1L as a Ferroptosis‐Linked Biomarker in Microsatellite States–Driven Colorectal Cancer: Functional and Diagnostic Insights From Multiomics Analysis},
journal = {Human Mutation},
year = {2025},
doi = {10.1155/humu/6663166}
}
EUVIMED